Dr. Charles Lin is a board-certified ophthalmologist and fellowship-trained cornea specialist. He spearheads the cornea transplant program at Stanford University and has launched cutting edge surgical procedures including ultra-thin DSAEK, DMEK, DSO, and DALK at Stanford. He leads clinical trials at Stanford focusing on cornea transplantation and ocular inflammation and infections. Dr. Lin received his AB in Environmental Science and Public Policy from Harvard University, graduating summa cum laude. He attended medical school at the University of California, San Francisco, where he received his M.D. with honors. He completed his ophthalmology residency at the University of California, San Francisco and Cornea, External Disease, and Refractive Surgery fellowship at the F.I. Proctor Foundation and University of California, San Francisco.